| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4ß1/VCAM-1 Interaction



* Department of Physiology and Biophysics, University of Miami School of Medicine, Miami, Florida, USA;
Wellcome Trust Centre for Cell-Matrix Research, School of Biological Sciences, University of Manchester, Manchester, United Kingdom; and
Celltech Group, Slough, United Kingdom
Correspondence: Address reprint requests to Vincent T. Moy, Dept. of Physiology and Biophysics, University of Miami School of Medicine, 1600 N.W. 10th Ave., Miami, FL 33136. Tel.: 305-243-3201; Fax: 305-243-5931; E-mail: vmoy{at}newssun.med.miami.edu.
Intercellular adhesion mediated by integrin
4ß1 and vascular cell adhesion molecule-1 (VCAM-1) plays a crucial role in both the rolling and firm attachment of leukocytes onto the vascular endothelium. Essential to the
4ß1/VCAM-1 interaction is its mechanical strength that allows the complex to resist the large shear forces imposed by the bloodstream. Herein we employed single-molecule dynamic force spectroscopy to investigate the dynamic strength of the
4ß1/VCAM-1 complex. Our force measurements revealed that the dissociation of the
4ß1/VCAM-1 complex involves overcoming at least two activation potential barriers: a steep inner barrier and a more elevated outer barrier. The inner barrier grants the complex the tensile strength to withstand large pulling forces (>50 pN) and was attributed to the ionic interaction between the chelated Mg2+ ion at the N-terminal A-domain of the ß1 subunit of
4ß1 and the carboxyl group of Asp-40 of VCAM-1 through the use of site-directed mutations. In general, additional mutations within the C-D loop of domain 1 of VCAM-1 suppressed both inner and outer barriers of the
4ß1/VCAM-1 complex, while a mutation at Asp-143 of domain 2 of VCAM-1 resulted in the suppression of the outer barrier, but not the inner barrier. In contrast, the outer barrier of
4ß1/VCAM-1 complex was stabilized by integrin activation. Together, these findings provide a molecular explanation for the functionally relevant kinetic properties of the
4ß1/VCAM-1 interaction.
This article has been cited by other articles:
![]() |
S. Liang and C. Dong Integrin VLA-4 enhances sialyl-Lewisx/a-negative melanoma adhesion to and extravasation through the endothelium under low flow conditions Am J Physiol Cell Physiol, September 1, 2008; 295(3): C701 - C707. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schmitz, M. Benoit, and K.-E. Gottschalk The Viscoelasticity of Membrane Tethers and Its Importance for Cell Adhesion Biophys. J., August 1, 2008; 95(3): 1448 - 1459. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Helenius, C.-P. Heisenberg, H. E. Gaub, and D. J. Muller Single-cell force spectroscopy J. Cell Sci., June 1, 2008; 121(11): 1785 - 1791. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. te Riet, A. W. Zimmerman, A. Cambi, B. Joosten, S. Speller, R. Torensma, F. N. van Leeuwen, C. G. Figdor, and F. de Lange Distinct kinetic and mechanical properties govern ALCAM-mediated interactions as shown by single-molecule force spectroscopy J. Cell Sci., November 15, 2007; 120(22): 3965 - 3976. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Abdulreda and V. T. Moy Atomic Force Microscope Studies of the Fusion of Floating Lipid Bilayers Biophys. J., June 15, 2007; 92(12): 4369 - 4378. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Alon, S. W. Feigelson, E. Manevich, D. M. Rose, J. Schmitz, D. R. Overby, E. Winter, V. Grabovsky, V. Shinder, B. D. Matthews, et al. {alpha}4{beta}1-dependent adhesion strengthening under mechanical strain is regulated by paxillin association with the {alpha}4-cytoplasmic domain J. Cell Biol., December 19, 2005; 171(6): 1073 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Brockwell, G. S. Beddard, E. Paci, D. K. West, P. D. Olmsted, D. A. Smith, and S. E. Radford Mechanically Unfolding the Small, Topologically Simple Protein L Biophys. J., July 1, 2005; 89(1): 506 - 519. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |